Logtenberg, Meike E. W. http://orcid.org/0000-0002-8981-1189
Jansen, J. H. Marco
Raaben, Matthijs
Toebes, Mireille
Franke, Katka
Brandsma, Arianne M.
Matlung, Hanke L.
Fauster, Astrid http://orcid.org/0000-0003-4608-5604
Gomez-Eerland, Raquel
Bakker, Noor A. M.
van der Schot, Simone
Marijt, Koen A. http://orcid.org/0000-0003-4396-0047
Verdoes, Martijn http://orcid.org/0000-0001-8753-3528
Haanen, John B. A. G. http://orcid.org/0000-0001-5884-7704
van den Berg, Joost H.
Neefjes, Jacques http://orcid.org/0000-0001-6763-2211
van den Berg, Timo K. http://orcid.org/0000-0002-2052-3904
Brummelkamp, Thijn R.
Leusen, Jeanette H. W.
Scheeren, Ferenc A.
Schumacher, Ton N. http://orcid.org/0000-0003-0517-8804
Article History
Received: 11 July 2018
Accepted: 14 January 2019
First Online: 4 March 2019
Competing interests
: M.E.W.L., M.R., T.R.B., F.A.S., J.H.W.L. and T.N.S. are inventors on a patent application that covers manipulation of the CD47-SIRPĪ± axis via QPCTL. T.N.S. is advisor for Adaptive Biotechnologies, AIMM Therapeutics, Allogene Therapeutics, Amgen, Merus and Neon Therapeutics; is a recipient of grant or research support from MSD, Bristol-Myers Squibb and Merck KgaA; is a stockholder in AIMM Therapeutics, Allogene Therapeutics, Merus, Neogene Therapeutics and Neon Therapeutics; and is venture partner at Third Rock Ventures. T.R.B. is cofounder and Scientific Advisory Board member of Haplogen GmbH and cofounder and managing director of Scenic Biotech. J.H.W.L. is founder, advisor and shareholder of TigaTx. J.H.B. is recipient of grant or research support from Bristol-Myers Squibb, Medimmune and Neon Therapeutics. K.F., H.L.M. and T.K.v.d.B are recipients of research support from Synthon Biopharmaceuticals BV. J.B.A.G.H. is advisor to Bristol-Myers Squibb, MSD, Novartis, Roche/Genentech, Pfizer, IPSEN, AZ/MedImmune, Bayer, Seattle Genetics, Immunocore, Gadeta, Neon Therapeutics, and Celsius Therapeutics, and is a recipient of grant or research support from Bristol-Myers Squibb, MSD, Novartis and Neon Therapeutics.